Terms: = Kidney tumors AND BCL2, Bcl-2, 596, ENSG00000171791 AND Prognosis
64 results:
1. BAG3 as a novel prognostic biomarker in kidney renal clear cell carcinoma correlating with immune infiltrates.
Gong B; Huang Y; Wang Z; Wan B; Zeng Y; Lv C
Eur J Med Res; 2024 Feb; 29(1):93. PubMed ID: 38297320
[TBL] [Abstract] [Full Text] [Related]
2. [Mechanism of nuclear protein 1 in the resistance to axitinib in clear cell renal cell carcinoma].
Liu YC; Wu ZL; Ge LY; DU T; Wu YQ; Song YM; Liu C; Ma LL
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 55(5):781-792. PubMed ID: 37807730
[TBL] [Abstract] [Full Text] [Related]
3. ORM1 promotes tumor progression of kidney renal clear cell carcinoma (KIRC) through CALR-mediated apoptosis.
Yu G; Gao J; Hu W; Hu D; Wang W; Yang S; Gao J
Sci Rep; 2023 Sep; 13(1):15687. PubMed ID: 37735575
[TBL] [Abstract] [Full Text] [Related]
4. BNIP3 as a potential biomarker for the identification of prognosis and diagnosis in solid tumours.
Yu Q; Fu W; Fu Y; Ye W; Yan H; Yu Z; Li R; Cai Y; Chen Y; Wang L; Wei X; Chen Y; Zhang Y; Ying H; Tang F; Dai F; Han W
Mol Cancer; 2023 Aug; 22(1):143. PubMed ID: 37649051
[TBL] [Abstract] [Full Text] [Related]
5. PI3K/Akt signaling in urological cancers: Tumorigenesis function, therapeutic potential, and therapy response regulation.
Rezaei S; Nikpanjeh N; Rezaee A; Gholami S; Hashemipour R; Biavarz N; Yousefi F; Tashakori A; Salmani F; Rajabi R; Khorrami R; Nabavi N; Ren J; Salimimoghadam S; Rashidi M; Zandieh MA; Hushmandi K; Wang Y
Eur J Pharmacol; 2023 Sep; 955():175909. PubMed ID: 37490949
[TBL] [Abstract] [Full Text] [Related]
6. Relation of beclin-1 and bcl-2 expressions with pathological parameters and prognosis in clear cell renal cell carcinomas.
Girgin RB; Ozkanli S; Engin-Zerk P; Soylemez T; Olgun ZC; Yildirim A; Kir G
Arch Esp Urol; 2022 May; 75(4):368-374. PubMed ID: 35818918
[TBL] [Abstract] [Full Text] [Related]
7. DRAM1 plays a tumor suppressor role in clear cell renal cell carcinoma through modulating Akt signaling.
Feng Q; Cheng M; Jin J; Zhang S; Bai Y; Xu J
Acta Histochem; 2022 Apr; 124(3):151874. PubMed ID: 35299128
[TBL] [Abstract] [Full Text] [Related]
8. Genetic profile and immunohistochemical study of clear cell renal carcinoma: Pathological-anatomical correlation and prognosis.
Diez-Calzadilla NA; Noguera Salvá R; Soriano Sarrió P; Martínez-Jabaloyas JM
Cancer Treat Res Commun; 2021; 27():100374. PubMed ID: 33932757
[TBL] [Abstract] [Full Text] [Related]
9. Expression of BAG1 is associated with prognosis in kidney renal clear cell carcinoma based on bioinformatics.
Wu H; Liu M; He Y; Meng G; Guo W; Guo Q
BMC Cancer; 2021 Feb; 21(1):160. PubMed ID: 33581726
[TBL] [Abstract] [Full Text] [Related]
10. Role of AMPK/mTOR-independent autophagy in clear cell renal cell carcinoma.
Radovanovic M; Vidicevic S; Tasic J; Tomonjic N; Stanojevic Z; Nikic P; Vuksanovic A; Dzamic Z; Bumbasirevic U; Isakovic A; Trajkovic V
J Investig Med; 2020 Dec; 68(8):1386-1393. PubMed ID: 33087428
[TBL] [Abstract] [Full Text] [Related]
11. lncRNA 00312 Attenuates Cell Proliferation and Invasion and Promotes Apoptosis in Renal Cell Carcinoma via miR-34a-5p/ASS1 Axis.
Zeng J; Li Y; Wang Y; Xie G; Feng Q; Yang Y; Feng J
Oxid Med Cell Longev; 2020; 2020():5737289. PubMed ID: 32308805
[TBL] [Abstract] [Full Text] [Related]
12. MiR-186 represses progression of renal cell cancer by directly targeting CDK6.
Guo Z; Lv X; Jia H
Hum Cell; 2020 Jul; 33(3):759-767. PubMed ID: 32266659
[TBL] [Abstract] [Full Text] [Related]
13. [Triple expressor lymphoma in a kidney transplant patient].
Aránguiz N; Vega J
Rev Med Chil; 2019 Feb; 147(2):247-250. PubMed ID: 31095175
[TBL] [Abstract] [Full Text] [Related]
14. Solitary Fibrous Tumor of kidney.
Lalwani AK; Faiq SM; Ahuja J
J Coll Physicians Surg Pak; 2018 Jul; 28(7):564-565. PubMed ID: 29950265
[TBL] [Abstract] [Full Text] [Related]
15. Interleukin-33 Predicts Poor prognosis and Promotes Renal Cell Carcinoma Cell Growth Through its Receptor ST2 and the JNK Signaling Pathway.
Wu CW; Wu YG; Cheng C; Hong ZD; Shi ZM; Lin SQ; Li J; He XY; Zhu AY
Cell Physiol Biochem; 2018; 47(1):191-200. PubMed ID: 29763892
[TBL] [Abstract] [Full Text] [Related]
16. MicroRNA-34a: A Key Regulator in the Hallmarks of Renal Cell Carcinoma.
Toraih EA; Ibrahiem AT; Fawzy MS; Hussein MH; Al-Qahtani SAM; Shaalan AAM
Oxid Med Cell Longev; 2017; 2017():3269379. PubMed ID: 29104726
[TBL] [Abstract] [Full Text] [Related]
17. An increase in long non-coding RNA PANDAR is associated with poor prognosis in clear cell renal cell carcinoma.
Xu Y; Tong Y; Zhu J; Lei Z; Wan L; Zhu X; Ye F; Xie L
BMC Cancer; 2017 May; 17(1):373. PubMed ID: 28545465
[TBL] [Abstract] [Full Text] [Related]
18. Distinct immunophenotypes and prognostic factors in renal cell carcinoma with sarcomatoid differentiation: a systematic study of 19 immunohistochemical markers in 42 cases.
Yu W; Wang Y; Jiang Y; Zhang W; Li Y
BMC Cancer; 2017 Apr; 17(1):293. PubMed ID: 28449664
[TBL] [Abstract] [Full Text] [Related]
19. [Molecular biological predictors for kidney cancer].
Vtorushin SV; Tarakanova VO; Zavyalova MV
Arkh Patol; 2016; 78(1):56-61. PubMed ID: 27077146
[TBL] [Abstract] [Full Text] [Related]
20. [Clinicopathologic features of solitary fibrous tumor in urogenital system].
Ruan HJ; Huang AH; Cheng S; Fu GX
Zhonghua Bing Li Xue Za Zhi; 2016 Apr; 45(4):248-51. PubMed ID: 27033388
[TBL] [Abstract] [Full Text] [Related]
[Next]
